caffeic acid phenethyl ester has been researched along with 2-acetylaminofluorene in 3 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (2-acetylaminofluorene) | Trials (2-acetylaminofluorene) | Recent Studies (post-2010) (2-acetylaminofluorene) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 2,352 | 0 | 97 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | 2-acetylaminofluorene (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.143 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.016 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.595 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.059 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.595 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.143 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 6.053 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arce-Popoca, E; Carrasco-Legleu, CE; Fattel-Fazenda, S; Hernández-García, S; Márquez-Rosado, L; Sánchez-Pérez, Y; Villa-Treviño, S | 1 |
| Alemán-Lazarini, L; Arce-Popoca, E; Arellanes-Robledo, J; Beltrán-Ramírez, O; Fattel-Fazenda, S; García-Román, R; Hernández-García, S; Salcido-Neyoy, M; Sierra-Santoyo, A; Vázquez-Vázquez, P; Villa-Treviño, S | 1 |
| Angeles, E; Beltrán-Ramírez, O; Macías-Pérez, JR; Martínez-Soriano, PA; Ruiz-Sánchez, MB; Salcido-Neyoy, ME; Vásquez-Garzón, VR; Villa-Treviño, S | 1 |
3 other study(ies) available for caffeic acid phenethyl ester and 2-acetylaminofluorene
| Article | Year |
|---|---|
A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model.
Topics: 2-Acetylaminofluorene; Animals; Caffeic Acids; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Cytotoxins; Diethylnitrosamine; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Gene Expression Regulation, Enzymologic; Glutathione S-Transferase pi; Lipid Peroxidation; Liver Neoplasms, Experimental; Male; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; RNA, Messenger | 2006 |
Evidence that the anticarcinogenic effect of caffeic acid phenethyl ester in the resistant hepatocyte model involves modifications of cytochrome P450.
Topics: 2-Acetylaminofluorene; Animals; Anticarcinogenic Agents; Caffeic Acids; Cytochrome P-450 Enzyme System; Diethylnitrosamine; gamma-Glutamyltransferase; Hepatocytes; Liver Neoplasms, Experimental; Male; Microsomes, Liver; Phenylethyl Alcohol; Rats; Rats, Inbred F344 | 2008 |
The effect of caffeic acid phenethyl ester analogues in a modified resistant hepatocyte model.
Topics: 2-Acetylaminofluorene; Acetanilides; Animals; Anticarcinogenic Agents; Antioxidants; Caffeic Acids; Carcinogens; Cell Division; Cinnamates; Diethylnitrosamine; Drug Evaluation, Preclinical; Drug Resistance; Glutathione S-Transferase pi; Hepatectomy; Hepatocytes; Ki-67 Antigen; Lipid Peroxidation; Liver Neoplasms, Experimental; Male; Molecular Structure; Phenylethyl Alcohol; Precancerous Conditions; Rats; Rats, Inbred F344; Transcription Factor RelA | 2013 |